Acute Intermittent Porphyria clinical trials at UCSF
1 research study open to eligible people
Acute Intermittent Porphyria is a rare disease that affects the way the body makes heme, a substance that carries oxygen in our blood. UCSF is currently recruiting for a clinical trial called "Longitudinal Study of the Porphyrias". The purpose of this trial is to learn more about this disease and its effects on people's health over time, including during pregnancy.
open to all eligible people
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
San Francisco, California and other locations
Our lead scientists for Acute Intermittent Porphyria research studies include Bruce Wang, MD.